Cesarean section (CS) is part of the standard of care in modern obstetrics. Its availability, practicity, high acceptance among patients, and the permanent improvement in surgical techniques, anesthesia, blood replacement, and neonatal care have popularized the procedure as a safe and reasonable alternative to vaginal delivery for any individual born in the twenty-first century. Beyond an established recommended rate of 15% for all births, presently the main challenge in obstetrical care is to limit its use to patients that need the procedure in order to keep an adequate perinatal outcome. The rate of CS has been used in many healthcare settings as an indicator of an individual or institutional obstetrical performance. The issue of overuse of CS as a birth alternative beyond clear maternal or fetal indications has received extensive analysis not only from the reproductive medicine point of view but also from neonatal, ethical, financial, and public health stakeholders. Its place in modern obstetrics, and its impact on short-and long-term maternal and neonatal outcomes, health financial budgets, and in public health policies, have positioned CS a mayor issue to take care of in modern medicine.
Our study found a clinically significant correlation between the lowest UtA PI value and birth weight in an unselected, low-risk pregnant population. Because fetal growth is a multifactorial process in which placentation is only one of the factors involved, the use of a single parameter such as Doppler velocimetry remote from the delivery to predict birth weight in a low-risk population seems to be less useful than in the high-risk population.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.